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The homeoprotein PDX1 is expressed throughout pancreatic development and is thought to play important roles at multiple stages. We
describe the properties of a tet-off regulatory scheme to manage the expression of Pdx1 in utero. Cessation of Pdx1 expression at
increasingly later gestational times blocked pancreatic development at progressive and morphologically distinct stages and provided the
opportunity to assess the requirement for Pdx1 at each stage. Embryonic PDX1 is depleted below effective levels within 1 day of the
initiation of doxycycline treatment of pregnant mice. We show that PDX1, which is necessary for early pancreatic development, is also
required later for the genesis of acinar tissue, the compartment of the pancreas that produces digestive enzymes. Without PDX1, acini do
not form; the precursor epithelium continues to grow and branch, creating a truncated ductal tree comprising immature duct-like cells. The
bHLH factor PTF1a, a critical regulator of acinar development, is not expressed and cells producing digestive enzymes are rare. This
approach should be generally applicable to study the in vivo functions of other developmental regulators with multiple, temporally distinct
roles.
D 2005 Elsevier Inc. All rights reserved.Keywords: Pancreas; PDX1; IPF1; Transcription factor; Organogenesis; TetracyclineIntroduction
Pdx1 (Ipf1) encodes a HOX-like homeoprotein thought
to play critical roles at several stages of embryonic
pancreatic development, although those roles are not well
understood. Pancreatic development begins with the evagi-
nation of a dorsal and a ventral epithelial bud from the0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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(embryonic days 8.5–9) (Pictet and Rutter, 1972; Slack,
1995). PDX1 is present at the onset of pancreogenesis as the
two epithelial buds form (Ohlsson et al., 1993), as the
epithelium grows and branches to form the network of
tubules composed of precursors to acinar and islet cells, and
during the development of both acinar and islet lineages
(Guz et al., 1995). PDX1 becomes progressively restricted
during the later phase of cellular differentiation until it
becomes localized principally to the endocrine cells of the
islets of Langerhans in the mature pancreas. In mouse
embryos lacking a functional Pdx1 gene, pancreatic growth
and development are arrested shortly after the emergence of
the prepancreatic buds (Ahlgren et al., 1997; Jonsson et al.,
1994; Offield et al., 1996), thereby preventing the study of286 (2005) 225 – 237
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major cell types (a, h, y, E, PP) that produce polypeptide
hormones (principally glucagon, insulin, somatostatin,
ghrelin and pancreatic polypeptide, respectively), nor exo-
crine tissue, comprising acini (which make the digestive
enzymes) and ducts (which produce the fluid that transports
the secreted acinar enzymes to the intestine), are formed. To
identify other developmental functions of Pdx1, a scheme to
experimentally manage its expression during embryogenesis
is necessary.
Targeted gene inactivation to examine the null phenotype
and forced transgenic expression to examine the effects of a
constitutively active form can be used to investigate gene
function in animals. Both approaches have limitations for
developmental control genes, however. For example, when
a gene needed for early development is ablated, embryonic
or neonatal lethality is nearly certain, making the study of
gene function later in development or in the mature animal
impossible. Similarly, for a gene such as Pdx1 with roles at
multiple stages during a developmental program, germline
inactivation can be informative only up to the time of its
first function critical to further development. Tissue-specific
gene-knockout strategies using Cre recombinase-based
deletion have partly overcome these limitations (Branda
and Dymecki, 2004). However, this programmed gene
inactivation (or activation) is limited by the number of
well-characterized promoters available with relevant spatial
and temporal expression properties and by the irreversible
nature of the recombination event that precludes gene
reactivation.
A potentially useful solution to these limitations allows
temporal management of a target gene by the application or
withdrawal of innocuous small molecule effectors. Pio-
neered by Gossen, Bujard and their colleagues with the
tetracycline-repressible transactivator, tTA (Furth et al.,
1994; Gossen and Bujard, 1992), the options have now
expanded greatly (Zhu et al., 2002). This approach is more
complicated, however, because it requires the inactivation of
both alleles of the endogenous locus and the introduction of
a regulatable copy of the gene as well as a gene encoding a
conditional transcriptional regulator, such as tTA. TheFig. 1. The designs of the tTA knock-in/out construct for the Pdx1 gene and t
and Results.effectiveness of this genetic regulatory strategy in animals
often has been incomplete. In this report, we demonstrate an
effective variation of the tet-off (Gossen and Bujard, 1992)
regulatory scheme to inactivate the expression of Pdx1 in
utero and identify additional developmental periods requir-
ing the presence of PDX1.
To control the transcription of Pdx1 in mice, we
substituted the amino acid coding sequence of the tetracy-
cline-transactivator (tTA-off) for that of the endogenous
Pdx1 locus by homologous recombination and introduced
a tTA-responsive transgene encoding PDX1 (Fig. 1 and
Holland et al., 2002). The tTA-for-Pdx1 substitution
coincidentally places tTA under the control of all the regu-
latory sequences of the endogenous Pdx1 locus and abo-
lishes production of PDX1 from that allele. As mice with one
active Pdx1 allele develop normally (Ahlgren et al., 1996;
Jonsson et al., 1994; Offield et al., 1996), these mice can be
maintained in a heterozygous state. To provide a tetracy-
cline-regulated source of PDX1, transgenic mice were
created bearing a bicistronic transgene (tetO-Pdx1) encoding
a Pdx1 minigene and a reporter gene (either nlacZ or EGFP)
linked through an IRES and driven by the tTA-responsive
promoter of Gossen and Bujard (1992). We previously
reported the use of this regulatory scheme to suppress Pdx1
expression in adult mice (Holland et al., 2002).
In this report, we describe the properties of doxycycline
regulation and the effects of Pdx1 inactivation on exocrine
pancreatic development in vivo. We show that inactivation
of the Pdx1 transgene just prior to the initiation of acinar
cell differentiation prevents that differentiation.Methods
Knock-in/out and transgenic mice
Construction of the vectors for the tTA knock-in/out of
the Pdx1 gene by homologous recombination in ES cells
and for the EGFP form of the bicistronic tTA-responsive
Pdx1 transgene has been described (Holland et al., 2002).
The LacZ form of this Pdx1 transgene has the h-he tTA-responsive Pdx1 transgene. The details are discussed in Methods
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Generation of mice bearing the altered (Pdx1tTA) allele and
creation of the transgenic mice bearing the EGFP form of
the bicistronic Pdx1 transgene were also described previ-
ously (Holland et al., 2002). Details of the knock-in/out and
transgene constructs, their optimization, and preliminary
tests in transfected cells are available on request. The
genotypes of mice and embryos were determined by PCR as
described (Holland et al., 2002). Treatment of pregnant mice
with doxycycline (Sigma, St. Louis, MO) was initiated with
a single administration by oral gavage (0.2 ml of a 1 mg/ml
solution) and maintained with 1 mg/ml doxycycline in
drinking water containing 5% sucrose.
Immunohistochemistry and immunofluorescence
Tissues dissected from embryos and adult mice were
fixed in 4% paraformaldehyde for several hours at 4-C,
dehydrated using increasing concentrations of ethanol up to
100%, treated with Clear-Rite 3 (Richard-Allan Scientific,
Kalamazoo, MI), and embedded in Paraplast Plus Tissue
Embedding Medium (Kendall, Mansfield, MA). Five micro-
meter thick tissue sections were dewaxed by heating at 60-C
for 30 min followed by immersion in Clear-Rite 3. Sections
were then rehydrated by immersion in decreasing concen-
trations of ethanol from 100% to 30%, followed by several
washes in water. Antigen retrieval was performed using
Antigen Unmasking Solutioni (Vector Laboratories Inc.,
Burlingame, CA) and microwave heating under conditions
standardized in our laboratory. After cooling to room
temperature, sections were equilibrated by several rinses in
PBS and blocked with 10% normal donkey serum (Jackson
Research Laboratories, West Grove, PA) in PBS for 1 h
at room temperature before the application of primary
antibodies.
Primary antibodies were diluted in 5% normal donkey
serum and were the following (the dilutions for immuno-
fluorescence (IF), IF with tyramide signal amplification (IF-
TSA), and immunohistochemistry (IHC) are noted): rabbit
anti-PDX1 (a gift from C.V.E. Wright, Vanderbilt U.)
(1:8000 IHC, 1:400 IF), rabbit anti-GLUT2 (a gift from
B. Thorens, Lausanne, Switzerland) (1:200 IF, 1:5000 IF-
TSA), guinea pig anti-glucagon (Linco, St. Charles, MI)
(1:10,000 IF), rabbit anti-amylase (MacDonald et al., 1977)
(1:2000 IF), goat anti-carbonic anhydrase II (Santa Cruz,
Santa Cruz, CA) (1:100 IF), mouse anti-cytokeratin 7
(Chemicon, Temecula, CA) (1:1000 IF-TSA), rabbit anti-
carboxypeptidase A (Chemicon) (1:1000, IF), rabbit anti-
HES1 (Tetsuo Sudo, Toray Pharmaceutical Research Lab)
(1:1000, IF-TSA), anti-beta-galactosidase (MP Biomedi-
cals) (1:400 IF). Application of primary antibodies was
overnight for immunofluorescence and 1 h for IF-TSA at
room temperature. Sections were incubated with the secon-
dary antibody for 1 h at room temperature. Secondary
antibodies were (with dilutions) FITC-conjugated donkey
anti-rabbit IgG (Jackson Research Laboratories, West Grove,PA) (1:200); and Rodamine Red-conjugated donkey anti-
rabbit, anti-goat, and anti-guinea pig IgG (Jackson Research
Laboratories) (1:200). Tyramide signal amplification was
performed with the TSA Kit from Molecular Probes
(Eugene, OR). Immunohistochemical detection used pero-
xidase-conjugated anti-rabbit or anti-guinea pig immuno-
globulins. Cover slips were mounted using the ProlongR
Antifade Kit (Molecular Probes) mounting medium.
Histochemical staining for b-galactosidase activity
Whole guts dissected from embryos and fetuses were
washed twice in cold PBS, and fixed at 4-C in Solution A
(100 mM potassium phosphate, pH 7.4, 5 mM EGTA, 2
mM MgCl2) containing 0.2% glutaraldehyde. Tissues were
permeabilized by three 10 min washes in Solution A
containing 0.02% NP40 and 0.01% 7-deoxycholic acid at
room temperature. Tissues were then stained for h-galacto-
sidase activity by incubation in Solution A containing 5 mM
each K3[Fe(CN)6] and K4[Fe(CN)6] and 0.5 mg/ml X-Gal
(Roche, Indianapolis, IN) at room temperature for several
hours on a rotating platform. Tissues were postfixed in 4%
paraformaldehyde for several hours at 4-C. For sectioning,
the fixed tissues were dehydrated using a graded series of
ethanol concentrations (70% to 100%) followed by two
washes in Clear-Rite 3 and then embedded in Paraplast Plus.
Tissue sections were lightly counterstained with Eosin-Y
(Richard-Allan Scientific). Wholemount, h-galactosidase-
stained embryos and guts for photography were first cleared
for several hours in Cedarwood Oil (Polysciences, Inc.,
Warrington, PA) following the ethanol dehydration steps.
Cleared tissues were imaged in several focal planes using an
Olympus SZX12 microscope equipped with an OptronicsR
(Goleta, CA) digital camera and Magnafire camera software
and a composite in-focus image was then generated for each
tissue using Image-Pro software (MediaCybernetics, Silver
Spring, MD).
Microscopy and imaging
Whole en bloc tissues were imaged using a Leica M420
dissection scope. Tissue sections were imaged for he-
matoxylin and eosin (H&E) staining and for immuno-
fluorescence using a Leica DMRXE microscope. Both
microscopes were equipped with a Hamamatsu color chilled
3CCD camera. Images were processed using Adobe Photo-
shop 7.0 (Adobe Systems, Inc., San Jose, CA).
Analysis of the neonatal epithelial remnant by digital
volumetric imaging (DVI) was performed by Microscience
Group, Inc., as described by Ewald et al. (2002). The 3D
image of the epithelial remnant was reconstructed without
the need for glass slide-mounted serial sections from the
images of 1500 pseudo-H&E-stained sections using RES-
View 3.0 volume visualization software.
For electron microscopy, dissected pancreatic remnants
were cut into pieces no larger than 1 mm3 and fixed by
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2.5% paraformaldehyde, 0.05% (w/v) picrinic acid in 0.1 M
cacodylate buffer (pH 7.35) for 3 h at room temperature,
followed by several rinses in 0.1 M cacodylate buffer (pH
7.35). After dehydration and embedding in epon, thin
sections were stained with uranyl acetate and lead citrate
and examined and photographed with a Zeiss EM109 elec-
tron microscope.
RT-PCR
Total cellular RNA was isolated from individual dis-
sected embryonic pancreas with TriZol Reagent (Invitrogen,
Carlsbad, CA) and from neonatal and adult pancreas using
the guanidine thiocyanate procedure (MacDonald et al.,
1987). RNA preparations from age- and genotype-matched
embryos were pooled, whereas RNAs from neonatal and
adult pancreas remained individual samples. One micro-
gram aliquots of RNA were reverse transcribed using
random primers (Invitrogen) and SuperScript II reverse
transcriptase (Invitrogen). For quantification, preliminary
experiments determined the number of PCR cycles for each
mRNA to be within the range for a proportional change in
the amount of product for the change of input cDNA.
Amplification products were detected by standard Southern
hybridization with a gene-specific oligonucleotide probes.
The amount of hybridization was measured with a
PhosphorImager and quantified using ImageQuant software
(Molecular Dynamics). The amount of amplified product
from the reactions within the range of proportional response
to template was averaged and used to quantify the level of
an mRNA relative to the level of the mRNA for actin.
PCR reactions consisted of 25 ng of cDNA template, 10
mM Tris–HCl (pH 9.0), 50 mM KCl, 0.1% Triton X-100,
1.0–1.5 mM MgCl2, 150 ng each oligonucleotide, 0.2 AM
each dNTP, and 1 unit Taq DNA polymerase (Roche) in a
50 Al reaction. Amplification conditions, including the PCR
primer pairs and Southern hybridization probes, for the
mRNAs of actin, the endogenous Pdx1, the transgenic
Pdx1, tTA, amylase, h-galactosidase, Ptf1a, carboxypepti-
dase A, and TBP are available on request.Results
tTA-mediated activation of the reporter transgenes in mice
At least three conditions must be met to create mice with
normal development in which all PDX1 is produced from a
regulated transgene: (i) replacement of the Pdx1 coding
region with that of tTA-off must create a Pdx1-null
phenotype; (ii) expression of tTA in the pancreas cannot
be deleterious to pancreatic development or function; and
(iii) a tetracycline-regulated, Pdx1 transgene must be able to
rescue pancreatic development in Pdx1tTA/tTA mice. The
creation of ES cell clones with the tTA-substitution in thePdx1 locus, the generation of mice carrying this modifica-
tion, and the creation of transgenic mice bearing the
bicistronic tetO-Pdx1-EGFP transgene have been described
(Holland et al., 2002). We generated tetO-Pdx1-nlacZ
transgenic mice similarly and emphasize the use of these
mice for developmental studies. The Pdx1-tTA knock-in/out
construct for homologous recombination and the tTA-
regulated Pdx1 transgene were designed to help ensure
efficient production of the tTA protein and, in turn, effective
levels of PDX1 (Fig. 1). Because a long and highly base-
paired 5V UTR can limit the rate of translational initiation,
we removed most of the 5VUTR of the Pdx1 mRNA in both
the knock-in/out and transgenic constructs.
Mouse embryos homozygous for Pdx1tTA do not form a
pancreas (Fig. 2B and Holland et al., 2002), consistent with
previous descriptions of the effects of Pdx1 gene inactiva-
tion (Jonsson et al., 1994; Offield et al., 1996). For mice
with a single Pdx1tTA allele, the formation of the pancreas
was normal (Fig. 2A); in adult mice, exocrine and endocrine
tissue masses and architecture were normal as well. Adult
Pdx1+/tTA mice gradually acquire an impaired endocrine
response to glucose challenge (Holland et al., 2002), just as
for mice with one allele disrupted by lacZ-insertion (Dutta et
al., 1998). Thus, although tTA expression may be delete-
rious to mammalian cells in certain instances (Saez et al.,
1997; Schokett and Schatz, 1996), we detected no effects on
pancreatic development or function.
We derived and tested eight independent transgenic lines
bearing either nlacZ- or EGFP-forms of the tetO-controlled
Pdx1 for their ability to produce sufficient PDX1 to rescue
pancreatic development in homozygous Pdx1tTA/tTA embryos.
Each of the eight transgenic founders was mated with
Pdx1+/tTA heterozygous mice, the Pdx1+/tTA;TgPdx1 offspring
were intercrossed, and the neonates were examined for pan-
creatic tissue (e.g., Fig. 2C) and genotyped by PCR. The
transgenic locus of five of the eight lines restored pancreatic
development of Pdx1tTA/tTA embryos to some extent (Table
1). The ability to rescue pancreatic development was not
correlated with transgene copy number. Three of the lines,
including the Pdx1-nlacZ line 958-1, appeared to rescue most
effectively andwere analyzed further. Approximately 1 out of
5 pups with the regulated genotype (PdxtTA/tTA;TgPdx1) from
these three lines was born without a pancreas. We do not
know the basis for this incomplete rescue penetrance;
however, the common observation that long tandem arrays
of transgenes are readily silenced (Garrick et al., 1998)
suggests that in some embryos the arrays either are not
activated or are inactivated during development. The use of
multicopy transgenes may not be the optimal strategy.
Modification of the other allele of the targeted gene (e.g.,
Pdx1) to make it tetracycline-regulated (e.g., tetO-Pdx1) may
be more effective and also would facilitate mating strategies
to provide a tetracycline-responsive, rescue genotype (i.e.,
Pdx1tTA/tetO-Pdx1). Nevertheless, an 80% rescue rate is
sufficient for the experimental purposes described in this
report.
Fig. 2. The Pdx1-nlacZ transgene conditionally rescues pancreatic development of Pdx1-deficient (Pdx1tTA/tTA) embryos. All images are of dissected viscera
from postnatal day 1 (P1) pups. (A) Normal pancreatic development of a Pdx1+/tTA;TgPdx1-nlacZ neonate. (B) For Pdx1-deficient embryos (Pdx1tTA /tTA),
only a very small pancreatic remnant (arrow and inset) forms. (C) A pancreas of nearly full size forms in embryos with the regulated genotype,
Pdx1tTA/tTA;TgPdx1-nlacZ. The pancreatic tissue stains blue due to the h-galactosidase staining derived from expression of nlacZ on the transgene. (D) Pancreatic
nuclei stain for h-galactosidase activity derived from the nlacZ transgene. (E) Neonates of the regulated genotype from mothers treated with doxycycline from
the morning of conception are born with small ductal remnants (arrow) derived from the ventral (v) and dorsal (d) pancreatic buds (F), very similar to the
pancreatic remnant of pups with the germline Pdx1 knock-out (B). sp, spleen; st, stomach; d, duodenum; p, pancreas.
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must coincide closely with that of the endogenous Pdx1
gene. Of principal concern was the additional intermediate
transcription step between activation of the Pdx1tTA locus
and the PDX1-expressing transgene. Embryonic expression
of the tetO-Pdx1 transgene, activated by tTA produced
from the Pdx1tTA allele, recapitulated the temporal and
spatial expression pattern of Pdx1 (Fig. 3). At E9.5,
transgenic h-galactosidase was present in the nascent
dorsal and ventral buds. By E11.5, expression of the
transgene had spread appropriately to the interveningTable 1
Rescue of pancreatic development by tetO-Pdx1 transgenes
Transgene Line Copy number # w/ re
Pdx1-nlacZ 957-8 19 2
958-1 39 30
958-2 8 3
958-6 18 2
958-9 52 1
Pdx1-EGFP 951-1 10 2
953-1 11 13
956-6 12 8
Totals 8 61
Total percent rescued 43/61 = 71%
Three most effective lines 34/43 = 79%
The ability of eight independent tetO-Pdx1 transgenic lines to rescue pancreatic d
rescue pancreatic development in Pdx1tTA/tTA embryos. Neonates were examined
estimated 50% or more of normal pancreatic size; Fpartial rescue_ was between 1
transgene copies for each line was determined by quantitative dot hybridization o
a Total number of newborn pups with the rescue genotype (PdxtTA/tTA;TgPdx1) tduodenum, the bile duct and the caudal stomach. All
PDX1-positive cells were also h-gal-positive, although the
levels of the two proteins were not always in the same
ratio (Figs. 3A–C). Subsequent expression marked the
branching epithelium precisely. At mid-development (Fig.
3, e14.5 and D), nearly all of the epithelial cells, including
those forming acini as well as islet cell clusters, stained for
h-galactosidase. At birth, h-galactosidase staining was
high in islet cells and low in acinar cells (Fig. 3E),
consistent with the maintenance of high Pdx1 expression
selectively in islet h-cells (Guz et al., 1995). Moreover, thescue genotypea Phenotype
Rescue Partial Apancreatic
1 1 0
20 3 7
0 0 3
0 2 0
0 0 1
0 0 2
6 5 2
2 3 3
29 (48%) 14 (23%) 18 (29%)
evelopment of Pdx1tTA/tTA embryos. Each line was tested for the ability to
for the presence of a pancreas. FRescue_ was applied to pups that had an
0 and 50%; apancreatic pups had no discernible pancreas. The number of
f genomic DNA with either EGFP or nlacZ probes.
ested.
Fig. 3. Developmental expression of the tetO-Pdx1 transgene recapitulates normal Pdx1 expression. Blue histochemical staining of h-galactosidase marks
the sites of transgene activity for embryonic organs of the 958-1 line at E9.5 through E17.5. The gut tube for E10.5 is outlined. Gut structures are
labeled as, antral stomach; bd, bile duct; d, duodenum; dp and vp, dorsal and ventral buds of the pancreas; gl and sl, gastric and splenic lobes of the
pancreas; sp, spleen; st, stomach. (A–C) Immunofluorescent images of an E11.5 pancreatic epithelium for PDX1, h-galactosidase and the two merged,
respectively. Scale bar = 20 Am. (D) Detection of transgenic h-galactosidase activity throughout the ventral and dorsal pancreatic epithelia from an
E14.5 embryo. Scale bar = 200 Am. (E) h-galactosidase activity persists in both islet (i) and acinar (arrowheads) cells in postnatal day 1 pancreas.
Scale bar = 20 Am.
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varied in concert during development (Fig. 4A), peaking
during mid-development at E13.5–15.5.
Control of the tetO-Pdx1/nlacZ transgene
To verify that the nlacZ-form of the tTA-controlled
transgene could be repressed in vivo, we administered the
tetracycline analogue doxycycline to adult mice that had
the tetO-Pdx1/nlacZ transgene and were heterozygous for
Pdx1tTA (Fig. 4B). Prior to treatment with doxycycline, the
transgenic Pdx1-nlacZ mRNA was measured from a biopsy
sample of each pancreas. The transgenic mRNA was
present only in those animals with both a Pdx1tTA allele
and the transgene. After 7 days of recovery from the biopsy,
doxycycline treatment was initiated for the same animals
by an oral gavage and maintained with 1 mg/ml doxycy-cline in the drinking water. After 7 days of treatment, the
level of the transgenic mRNA decreased at least 50-fold
(Fig. 4B).
Doxycycline repression of pancreatic development
For embryos with the regulated genotype (PdxtTA/tTA;
TgPdx1), dox-treatment of the mothers from the morning of
conception through birth prevented the development of a
pancreas (compare Figs. 2A and E). Only very small
epithelial remnants formed (Fig. 2F), which are character-
istic of the germline Pdx1-knockout phenotype (Fig. 2B and
Ahlgren et al., 1996; Offield et al., 1996). Initiating dox-
treatment just prior to (E7.5) or at the onset of (E8.5) Pdx1
expression produced similarly truncated epithelial remnants
(Fig. 5). Thus, dox-treatment quickly and effectively
blocked further pancreatic development.
Fig. 4. Control of Pdx1 mRNA levels in embryonic and adult mice. (A)
During embryonic development, the mRNA of the Pdx1 transgene profiles
that of the endogenous Pdx1 gene during embryonic development. RT-PCR
analysis used gene-specific primers for the Pdx1 and nlacZ portions of the
bicistronic transgenic mRNA, endogenous Pdx1+ mRNA, and actin mRNA.
Each PCR product was detected by Southern hybridization with a
corresponding gene-specific oligonucleotide probe. The cDNA templates
were derived from duplicate reactions without () and with (+) reverse
transcriptase with RNA isolated from dissected pancreatic rudiments for
E11.5 through postnatal day 1 (P1). (B) Doxycycline-treatment suppresses
tTA-induced expression of the Pdx1-nlacZ transgene in adult mice. Prior to
doxycycline-administration (-Dox), RNA was isolated from each of four
adult mice representing normal (mouse 1), a single altered Pdx1 allele (mouse
2), a transgenic locus (mouse 3), and both modifications (mouse 4).
Expression of the transgene (measured by amplification of the nlacZ cistron)
requires tTA. After recovery, eachmouse was administered doxycycline for 7
days and RNA was isolated from the remaining pancreas. Dox-treatment
nearly eliminates the transgenicmRNA.RT-PCR analysis was performed and
the products detected by Southern hybridization as described in Methods.
Actin mRNAwas measured to verify approximately equal assay conditions.
Fig. 5. Stepwise delayed doxycycline treatment resolves a progression of
developmentally arrested structures. Dox-treatment was initiated by oral
gavage at the days of gestation indicated and continued by inclusion in
the drinking water. All images are of P1 pups. Arrows indicate pancreatic
remnants. Insets are bright field images that show better the outlines of
the pancreatic ductal epithelia. Normal pancreatic development is
shown in the bottom right-most panel; this animal had the genotype
Pdx1+/tTA;TgPdx1-nlacZ. Abbreviations are the same as for Fig. 3.
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stage, repression of the Pdx1-transgene and turnover of the
transgenic PDX1 protein must occur more quickly than the
duration of the stage. Indeed, application of Dox to mothers
on day 11.5 of gestation rendered Pdx1 mRNA nearly
undetectable in Dox-responsive embryos within 1 day (Fig.
6C) and the level of PDX1 protein was dramatically reduced
(Fig. 6B). Epithelial morphogenesis diminished (compare
panels 12.5 and +1d of Figs. 6A, B), indicating that PDX1
function became limiting well before 24 h of Dox-treatment.
After 2 days, Pdx1 mRNA was more than 1000-fold lowerthan the normal E13.5 level, PDX1 protein was undetectable
by immunohistochemistry, branching morphogenesis had
stopped, and the epithelium formed abnormal, highly
columnar ducts. These early effects of Dox were reproduced
in three independent experiments. Thus, Dox-treatment
initiated on E11.5 eliminates PDX1 prior to the beginning
of the secondary transition at ¨E13.5 and blocks further
morphogenesis.
Beginning dox-treatment at later intervals resolved a
progression of developmentally arrested pancreatic struc-
tures formed by the depletion of PDX1 at successively later
developmental times (Fig. 5). Thus, doxycycline from E9.5
allowed growth of a linear epithelial tube with nascent
invaginations that represent the beginning of primary
branching. Doxycycline from E11.5 left a larger but crude
duct-like structure with a few primary branches distally.
Dox from E12.5 allowed the formation of extensive fine
structure, which upon microscopic examination consisted
of immature acini and associated small ductules (see
below). The stepwise progression from a linear tube, to
primary branches of large ducts, to secondary branches
connecting acinar cell clusters (Fig. 5) defines the major
morphogenetic changes of normal exocrine pancreatic
development.
Fig. 6. Doxycycline-induced depletion of transgenic PDX1 is rapid. (A) Expression of the endogenous Pdx1 gene is continuous. Immunohistochemical staining
for PDX1 in genetically unaltered embryos (except E12.5d) is shown for E9.5 through E13.5. The E12.5 panel is from a Pdx1+/tTA;TgPdx1 littermate of the Dox-
responsive embryo of the +1d panel of part B; the presence of an unaltered Pdx1 allele supports normal development in the presence of Dox. The epithelia of the
stomach (stom), duodenum (duod) and the dorsal (db) and ventral (vb) pancreatic buds are indicated. The filled arrowheads point to clusters of early endocrine
cells, which do not immunostain for PDX1. (B) Transgenic PDX1 in Dox-responsive embryos (Pdx1tTA/tTA;TgPdx1) disappears during 2 days of continuous Dox-
treatment. Dox was administered to pregnant females at E11.5 and embryonic visceral organs were obtained 1 and 2 days later. The morphological differences at
E12.5 are representative of those observed for three independent experiments with separate litters. Sections were lightly counterstained with eosin. The asterisks
mark the ages and treatments that were examined by RT-PCR in part C. Scale bars in panels of A and B = 100 Am. (C) The transgenic Pdx1 mRNA is nearly
undetectable by RT-PCR after 1 day of Dox-administration. The amplification products are shown for 25, 28, and 31 amplification cycles and compared to the
results for the TATA-binding protein (TBP) mRNA, which does not change in response to Dox. Hybridization signals were quantified by ImageQuant software
from Phosphor-Images (Molecular Dynamics). Embryonic RNAs were isolated from dissected pancreatic rudiments and amplification templates from cDNA
synthesis reactions without () and with (+) reverse transcriptase (RTase) were used to show the absence of a genomic DNA contribution to the PCR product.
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development
The most pronounced morphogenetic differences oc-
curred between doxycycline initiation at E11.5 (PDX1-
depletion by E12.5) and E12.5 (PDX1-depletion about
E13.5). With PDX1-depletion at E12.5, dorsal and ventral
remnants were present at birth (Fig. 7A); each was composed
of a convoluted, partly branched duct-like epithelium of
columnar cells encased in mesenchyme (Fig. 7B). Acinar-
like cell clusters (Fig. 7B, open arrow) were rare (compare
with Fig. 7H). A three-dimensional reconstruction of the
epithelium shows an anastomosing duct-like network
embraced by blood vessels (Fig. 8A). The distal tips of the
duct-like remnant, which may have benefited from earlier
and therefore longer Pdx1 expression, have finer branches.
The cells of the duct-like epithelium have a single cilium on
the luminal plasmalemma (Fig. 8B), characteristic of both
embryonic (Githens, 1989) and mature duct cells and distinct
from acinar cells (Aughsteen, 2002). Although the epithelial
structures look superficially like ducts, the cells are columnar
rather than cuboidal (Fig. 7B, inset) and markers of ductal
differentiation are either low (carbonic anyhdrase II; CAII)
or absent (cytokeratin 7; CK7) (Fig. 7E). Prior to the onset of
cellular differentiation, the epithelium of normal embryonic
pancreas expresses glucose transporter 2 (GLUT2), whereas
mature ducts and acini do not (Pang et al., 1994). Thecontinued presence of GLUT2 in the duct-like epithelium at
birth (Figs. 7C, D) also indicates that the premature depletion
of PDX1 arrests ductal differentiation.
The block in acinar cell formation is reflected in the nearly
complete loss of the mRNAs and proteins of amylase and
carboxypeptidase A (CPA), digestive enzymes characteristic
of differentiated acinar cells (Fig. 9). During normal develop-
ment, amylase and CPA mRNAs increase logarithmically
between E11.5 and E15.5 (Fig. 9 and Han et al., 1986) as the
acinar lineage is defined and differentiation begins. PDX1-
depletion from E12.5 decreases the accumulation of CPA and
amylase mRNAs approximately 75- and 270-fold, respec-
tively, by E15.5. The digestive enzyme mRNAs continue to
rise for 1 day at a rate similar to that of normal development,
then decrease after PDX1 falls below effective levels. The
decrease reflects the nearly complete absence of acinar cell
formation. The rare acinar-like cell clusters (Fig. 7B) present
at birth contain low levels of CPA and amylase (Figs. 7F, G).
These acini are continuous with the GLUT2-stained ductal
epithelium, but do not stain for GLUT2 (Fig. 7), consistent
with the expression of the acinar differentiation markers.
PTF1a is a bHLH transcription factor that becomes res-
tricted to mature acinar cells and is the key transcriptional
regulator of the digestive enzyme genes, including CPA and
amylase (Cockell et al., 1989; Krapp et al., 1996; Rose et al.,
2001). PDX1-depletion at E12.5 decreases Ptf1a mRNA
about 90-fold, indicating that PDX1 is necessary for the nor-
Fig. 7. The depletion of PDX1 at mid-pancreatic development blocks the transition from poorly branched, duct-like epithelium to highly branched ductules
with immature acini. Pancreatic remnants are from neonates exposed to doxycycline from E11.5 to birth. (A) Whole remnant with epithelia derived from the
dorsal (d) and ventral (v) pancreatic buds. (B) H&E-stained longitudinal section shows the highly columnar dorsal epithelium (inset) coursing through
mesenchyme. The arrowhead indicates an isolated endocrine cell within the epithelial tube. Open arrow, a rare acinar structure; arrow, region enlarged in the
inset. Scale bar = 0.5 mm, for panels B, C, and H. (C) The adjacent section was immunostained for GLUT2. (D) Amylase is present in small epithelial buds
with diminished GLUT2; arrowheads point to epithelial bridges to the duct-like epithelium. (E) The epithelium has low carbonic anhydrase II (CAII) and no
detectable cytokeratin 7 (CK7). The rare, immature acini co-express the acinar markers CPA (F) and amylase (G), from adjacent sections. Connections to the
duct-like epithelium are outlined in white. The scale bars in panels D–G = 20 Am. (H) A small region of the extensive acinar tissue of a normal neonatal
pancreas. i, forming islet; d, duct.
Fig. 8. Properties of the duct-like remnant from neonates treated with
doxycycline from E11.5. (A) Three-dimensional reconstruction of the
epithelium (yellow) shows a branched ductal structure with associated
blood vessels (orange). Note that anastomoses are present. The sample was
analyzed by Surface Imaging Microscopy by Resolution Sciences
Corporation as described by Ewald et al. (2002). Scale bar = 200 Am.
(B) The luminal surface of the duct-like epithelium has numerous small
microvilli and a single cilium (arrow) for each cell; Scale bar = 2 Am.
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lopment, PTF1a is undetectable by immunofluorescence in
the entire neonatal pancreatic remnant, including any
immature acini, after dox treatment from E11.5 (data not
shown).
To determine whether acinar cells form during PDX1-
depletion and then disappear or simply never form, we
examined pancreatic remnants from E14.5 embryos exposed
to dox from E11.5. During normal development, nascent
acini begin to appear at E13.5. At E14.5, morphologically
distinct preacinar structures containing CPA are evident
around the periphery of the pancreatic rudiment and
endocrine cell clusters form in the gland center (Figs. 10A,
B). Rudiments from dox-treated embryos do not produce
preacini (Fig. 10C) and CPA-immunostained cells are rare
(Fig. 10D), although endocrine cell clusters remain. Notch-
signaling, which is required for proper pancreatic develop-
ment (Apelqvist et al., 1999; Hald et al., 2003; Murtaugh et
al., 2003), is disrupted: HES1, normally present in the
tubular epithelium (Esni et al., 2004) is absent after dox-
treatment (compare panels E and F of Fig. 10). The absence
of preacini and the mRNAs for early acinar cell markers
indicates that PDX1 is required to initiate the acinar lineage.
Fig. 9. Inhibition of the accumulation of acinar specific mRNAs by Dox-
repression of Pdx1. mRNA levels were measured by quantitative RT-PCR
(see Methods) with total RNA isolated from embryonic pancreatic
rudiments dissected from embryos with and without maternal Dox-
treatment beginning at 11.5 days of gestation. The level of each mRNA
is expressed relative to its level at E11.5; note that the vertical axis is
logarithmic. Dashed lines, without dox; solid lines, with dox. The fold-
decreases of mRNA levels due to dox-treatment are indicated.
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continued epithelial growth and branching created a larger
remnant with a much smaller proportion of primitive duct
(Figs. 11A, B). Most of the remaining duct-like tissueFig. 10. Absence of PDX1 prevents the formation of acini rather than their mai
embryonic pancreas at E14.5. Recently formed preacini (red outlines) appear at the
and the tubular precursor epithelial tree (black outline) extends from center to th
nearby section for the same endocrine cluster indicated by the green asterisk. The sc
CPA to peripheral cell clusters identifies the preacini in a section nearby that of pa
(C) A representative section of the much smaller remnant from an E14.5 embry
approximately 10% of normal. Recognizable preacinar structures are absent. A clu
Immunofluorescence of a section near to that of panel C shows the relative absenc
cluster continued from panel C. The epithelium is outlined in white. (E) In normal
GLUT2-positive (red) epithelia (e.g., arrow) and mesenchyme (arrowheads). (F)
positive (red) epithelium but still present in the mesenchyme (arrowheads) at E14expressed GLUT2 and CAII, but not CK7 (Figs. 11C, D).
Sparse CK7-staining indicates the formation of occasional
regions of differentiated duct (Fig. 11D). The duct-like
epithelium was largely replaced by numerous eosinophilic
cell clusters that lacked the ductal markers CK7 and CAII
(Figs. 11D–F). The cells of these clusters are polarized
(extensive apical cytoplasm and basally located nuclei),
arranged around a central lumen, and reminiscent of
immature acini (Fig. 11bV). Compared to normal neonatal
acini (Fig. 11aV), these have many more cells per acinus, less
cytoplasm, and lower levels of the acinar markers CPA and
amylase. In addition, numerous smaller ductules appear that
connect directly to the immature acini (Fig. 11cV) and do not
stain for GLUT2 (Figs. 11B, C). The appearance of ductules
and acini indicates that three developmental processes were
initiated prior to PDX1-depletion at approximately E13.5:
new epithelial branching generating ductules that connect
acini to the large ducts, acinar morphogenesis, and acinar
cell differentiation. The presence of the immature acini at
birth shows that once acinar differentiation has begun,
PDX1 is not required to maintain these cells, but is required
to complete their differentiation.Discussion
Pdx1 is expressed in the developing pancreatic epithelium
throughout mouse embryonic pancreatic development (Guz
et al., 1995; Leonard et al., 1993). Germline inactivation of
Pdx1 demonstrated that it is necessary for the early phase ofntenance. (A) H&E-stained section through the center of a normal mouse
periphery, endocrine cell clusters (green outlines) accumulate in the interior,
e peripheral preacini. Inset: immunofluorescent detection of glucagon in a
ale bar represents 100 Am for three panels A–D. (B) Immunolocalization of
nel A. Secreted CPA fills many ductal and acinar lumens (e.g., arrowheads).
o with regulated Pdx1 after dox-treatment from E11.5. Epithelial mass is
ster of glucagon-expressing endocrine cells is retained (green outline). (D)
e of CPA (compare panel B) and the presence of glucagon in the endocrine
e14.5d pancreas, HES1 (green immunofluorescence) is present in nuclei of
After dox-treatment from e11.5, HES1 (green) is absent from the GLUT2-
.5.
Fig. 11. The depletion of PDX1 by dox-treatment beginning E12.5 permits the transition to highly branched ductules with immature acini. (A) P1 remnant with
acinar clusters. (B) H&E-stained longitudinal section shows large numbers of plump, eosinophilic, immature acini, and smaller amounts of columnar
epithelium. The arrow indicates the acinus enlarged in bV. Insets: (bV) immature acinus with larger number of smaller cells with less cytoplasm compared to a
normal P1 acinus (aV); (cV) narrow ductules (arrowheads) branching from a larger duct. (C) The remaining columnar duct expresses GLUT2. (D) The ductal
tissue retains CAII and discrete sections now contain cytokeratin 7. The acinar structures contain both carboxypeptidase A (E) and amylase (F). Panels D, E,
and F show similar regions of nearby, but nonadjacent, sections.
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al., 1994; Ahlgren et al., 1996; Offield et al., 1996). We used
a tetracycline regulatory scheme to show that PDX1 is
subsequently required during mid-pancreatic development
for cellular differentiation. Depletion of PDX1 after the early
phase of pancreatic growth and morphogenesis blocks the
next developmental phase, the onset of acinar and islet
development. Our results prove that PDX1 is required for the
initiation of the acinar lineage and not just for the elaboration
of the precursor epithelium from which the acinar lineage
derives. The efficacy of this experimental approach indicates
that it can be generally useful to analyze temporally separate
functions of regulators during an extended developmental
process such as organogenesis. It provides a means to
distinguish whether a developmental regulator is required
before or during a developmental transition. In this instance,
PDX1 is necessary during the formation of the epithelium
from which the acinar cells arise and subsequently for the
transition of the precursor epithelium to nascent acini.
The control of Pdx1 function in vivo by doxycycline was
sufficiently precise to resolve distinct stages of epithelial
development. Administration of doxycycline to pregnant
females at successively later intervals between E7.5 and
E12.5 showed that PDX1 is necessary for growth andstepwise branching of the pancreatic epithelium. Dox-
treatment early, at E7.5 or E8.5, prevented outgrowth of
the pancreatic buds. Delaying application to E9.5 allowed
the growth of a linear duct-like epithelium with invagina-
tions at regular intervals that mark the sites for secondary
branches. Dox-administration at E11.5 (with PDX1-deple-
tion by E12.5) permitted further growth of the epithelium
and the extension of the secondary branches. At birth, the
PDX1-depleted remnants were approximately 10% normal
size; consequently, PDX1 is required for growth as well as
differentiation. Nonetheless, in the absence of PDX1, the
ductal epithelium still grew approximately 10-fold from
E15.5 to birth (data not shown), but the formation and
growth of islet and acinar epithelia, which predominate late
in pancreatic development, do not begin. Depletion of
PDX1 shortly after the initiation of acinar development (dox
at E12.5 with PDX1-depletion estimated at about E13.5)
permits the formation of finer ducts and immature acini, but
limits acinar growth and prevents complete differentiation.
Acinar development
Depletion of PDX1 at E12.5 halts epithelial differ-
entiation just prior to the formation of acini. After 48 h of
M.A. Hale et al. / Developmental Biology 286 (2005) 225–237236depletion, the absence of preacini at E14.5, 1 day after they
begin to appear during normal development, indicates that
they do not initially form and disappear by birth. The
epithelium appears blocked at an intermediate ductal
phenotype with mixed properties of precursor epithelium
(GLUT2 expression) and partial ductal differentiation (low
CAII, but no CK7). Cells expressing acinar markers amylase
and CPAwere rare, and likely, the progeny of a few cells that
had begun acinar differentiation just before PDX1 was
depleted. This reproducible phenotype contrasts with that of
pancreatic remnants when PDX1 was depleted a day later
(E13.5). In this case, the delayed depletion of PDX1 allows
the transformation of much of the duct-like epithelium to
immature acini. The presence of these immature acini at birth
suggests that after acinar fate has been specified, PDX1 is
still required to complete the differentiation program. It is
also possible that the delayed depletion of PDX1 at E13.5
allows the complete differentiation of this population early,
but the level of differentiation is not maintained in the
absence of PDX1. We consider this less likely, because
PDX1 is not required to maintain the differentiated state of
adult acinar cells (Holland et al., 2002).
The depletion of PDX1 prevents the accumulation of the
mRNA for the PTF1a transcription factor. Because PTF1a is
the acinar specific component of a bHLH factor complex
that binds and activates the promoters of the digestive
enzyme genes, it is likely that the lack of CPA and amylase
gene products is due to the absence of PTF1a. The loss of
PTF1a indicates that PDX1 is required either for Ptf1a
transcription or for the formation of acinar precursor cells
capable of activating Ptf1a.
Ductal development
The ductal system of the mature pancreas comprises the
two main pancreatic ducts that drain into the intestine, small
interlobular ducts that link the structural units of the acinar
pancreas (lobules) to the main drainage, smaller intralobular
ducts, and fine intercalated ducts that connect to acini
(Ashizawa et al., 1997; Githens, 1989). The duct-like
structure that forms after PDX1-depletion at E12.5 appears
to represent incomplete main ducts (one from each bud),
primary branches from the main ducts (the interlobular
ducts), and the beginning of secondary branches distally
(intralobular ducts). The large ducts are similar to and
developmentally related to the common bile duct (Offield et
al., 1996; Sumazaki et al., 2004). In the absence of PDX1
after E12.5, growth of the large ductal system continues until
birth, but the small ducts, intercalated ducts, and acini do not
form.
The coincidental absence of intercalated ducts and acini in
the PDX1-depleted remnants is consistent with a concerted
developmental program that embraces both cell types and is
distinct from the program for the large ducts, which may be
shared with the common bile duct. The program of large duct
formation appears to separate from the acinar program atapproximately E12.5 (Gu et al., 2002). Lineage tracing using
the indelible Cre-lacZ genetic marker indicated that prior to
E12.5 the precursor cells of the large ducts and acini share
Pdx1 expression. After E12.5, the acinar lineage continues
Pdx1 expression, whereas the ductal lineage does not. This
resolution of the acinar and large-duct lineages at about
E12.5 is consistent with our results. Depletion of PDX1 at
E12.5 allows the formation of an extended tree of large
ducts; but neither acini nor ductules form. However, PDX1-
depletion about 1 day later allows the formation of acini and
ductules similar to intercalated ducts.
In the mature gland, centroacinar cells are the transitional
intercalated duct cells at the entrance of acini. Esni et al.
(2004) have proposed that embryonic centroacinar cells
demarcate the transition between the acinar precursor cells
and the differentiating acinar cells in a continuous epithelium.
Whereas the precursor cells have high levels of HES1
(generally thought to be an inhibitor of differentiation; Iso
et al., 2003), the embryonic Fcentroacinar cells_ have lower
levels of HES1 and no amylase, and the adjacent acinar cells
have amylase, but no HES1. Thus, the embryonic centro-
acinar cells may be the transitional cells in a concerted
developmental process that gives rise to acini and associated
intercalated ducts. The depletion of PDX1 at E12.5 disrupts
proper Notch-signaling, so that epithelial Hes1 expression is
lost. PDX1 may be required, in part, to maintain Notch-
signaling as a component of the acinar developmental
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